Human papillomaviruses (HPVs) have been proposed to be the most important etiological factors for cervical cancer although different agents may act in conjunction. Herpes simplex virus type 2 (HSV-2) infection is considered as a possible cofactor to malignant transformation. To examine the influence of HSV-2 infection on the HPV genes expression, CaSki cells bearing 60 to 600 copies ofHPV-16 DNA per cell were used as a model system. Twenty hours post HSV-2 infection the mRNA transcripts for HPV-16 early (El, E2 and E6) and late (Ll) genes were analysed by RT-PCR assay. Results indicated that the level of transcription of El, E2 and E6 genes was up to 3-fold enhanced in HSV-2 infected CaSki cells suggesting that HSV -2 infection could increase the risk of cervical cancer by overexpression of both HPV regulatory and oncogenic genes.
Human papillomaviruses (HPVs) are a group of viruses which induce proliferative lesions of skin and mucosa and HPV infection is the main cause of invasive cervical cancer (1-2). HPV 16 and 18 genotypes are considered high-risk papillomaviruses since they account for greater than 50% of all HPV DNA positive cervical carcinomas in multi-institutional studies (3) (4) (5) . These oncogenic genotypes are found in different human cervical carcinoma-derived cell lines, including CaSki, SiHa and HeLa cells in which HPV DNA persists in an integrated state, although in many cases extra chromosomal viral DNA can be also revealed (5) (6) (7) .
HPV DNA codifies for different early (El-E7) and two late proteins (Ll and L2). Among early proteins, at least three have growth stimulating and transforming properties (E5, E6 and E7). Commonly, following integration, HPV El and E2 open reading frames (ORFs) are disrupted whereas E6 and E7 ORFs are preserved, consequently deregulating the E6 and E7 gene expression . The E6 and E7 proteins of oncogenic HPV s are thought to playa critical role in immortalization and malignant transformation of cervical epithelial cells by interfering with the function of two tumor suppressor proteins, p53 and Rb respectively (5) .
Because of the hypothesis that over-expression of E6 and E7 oncoproteins is involved in tumor genesis, cervical carcinoma cell lines are often used as model system for malignant transformation studies. In fact, previous investigations demonstrated the presence of multiple copies ofHPV 18 DNA in Hela cells (9) and of HPV 16 DNA in CaSki cells (10) . In both these cell lines, transcription of the HPV genome is limited predominantly to the E6 and E7 ORFs (7) . In particular Caski cells contain 60-600 copies per cell ofHPV 16genome integrated in cellular DNA. Studies on the integration sites revealed many chromosomal sites of HPV 16 integration and analysis of the three most abundant BamHI clones from the Caski line showed that these consisted of full-length 7.9-kb HPV 16 genomic DNA (11). These HPV 16 sequences were arranged in the host chromosomes as headto-tail, tandem repeated arrays, indirectly supporting a trans-acting function of HPV mediated cell transformation (7) .
However, HPV is neither necessary nor sufficient in the etiology of cervical cancer, and a multifactorial etiology has been hypothesised (12) . Several studies have highlighted the significance and the importance of the link between herpes simplex virus type 2 (HSV-2) and cervical cancer suggesting that the etiology of cervical neoplasia in humans could be the result of an interaction between different DNA viruses (13) (14) (15) (16) (17) . Inactivated HSV-2 has been shown to transform cells in vitro (18) and, although HSV -2 DNA has been rarely detected in cervical tumors, it has been postulated that it may act on host cellular DNA by a hit-andrun mechanism (19) .
Some in vitro studies have investigated the putative relationship between HPV and HSV-2 infections. In HPV -immortalised keratinocytes it has been demonstrated that the XhoII sub-fragment of the HSV-2 genome may induce the malignant transformation (20) . Hara and coIl. (21) showed that HSV infection causes amplification of HPV 18 genomic DNA in HeLa cells, indicating the possibility of HSV involvement in the integration and amplification of HPV in host cells. In a recent study we demonstrated that HSV -2 infection in HeLa 229 cells induces a modulation of HPV 18 El and E6 early genes, resulting in a 9-fold and 3fold increased transcription, respectively (22) .
To date, however, little is known about the relationship between HSV-2 infection and cervix carcinoma cells bearing HPV 16 genome. Thus, to add further insight on the influence ofHSV-2 as cofactor ofHPV infection in the etiology of invasive cervical cancer, we carried out an in vitro study using the CaSki cervical cancer cell line as a model system for examining HSV-2 and HPV 16 interactions.
MATERIALS AND METHODS

Cells
Human cervical carcinoma cells (CaSki) were purchased from "Istituto Zooprofilattico Sperimenta-le" (Brescia-Italy). CaSki cells were cultured at 37°C in RPM I containing 1.2 gil NaHCO, and supplemented with 10% foetal calf serum, 2 mM glutamine, 100 lUI ml penicillin and 100 mglml streptomycin.
Virus HSV-2 strain G was propagated in Vero cells and the virus concentration was estimated by plaque assay, as already described (23) .
HSV-2 infection of CaSki cells
The infection with HSV -2 was performed in semiconfluent monolayers of CaSki cells (2x 10 6 cells175 em-flask) using HSV-2 at multiplicity of infection of 0.5 pfulcell. Virus was added to cell mono layers during adsorption step for I hat 4°C. After removal of virus inoculum, fresh maintenance medium was added and the temperature was shifted to 37°C to allow viral penetration. Twenty hours post infection (p.i.), when the cytopathic effect of HSV -2 was not yet detectable, the monolayers were washed in phosphate buffer saline (PBS) and cells collected for RNA extraction, in parallel with control cultures treated in the same way but not infected. To determine viral antigen synthesis, CaSki cells, grown in 8-well microtissue chamber slides for 24 h in 5% CO 2 , were washed and infected with HSV-2 at a multiplicity of 0.5 pfulcell. After 20 h at 37°C the cells were washed in PBS, fixed an acetone at -20°C for 5 min, incubated with rabbit anti-HSV-2 antibodies (DAKO) for 45 min at 37°C and washed in PBS. Viral antigen synthesis was estimated by utilising (FITC)coniugated anti-rabbit gammaglobulin antibodies (Sigma Chemical Company) and an UV Leitz microscope.
RNA extraction and reverse transcriptasepolymerase chain reaction conditions for £1, £2, £6 and L1 mRNA detection
Poly/A)" mRNA and DNA were extracted by Nucleobond AX-Clontech (M-Medical) according to the manufacturer's instructions. Reverse transcription of 200 ng of purified mRNA was performed by oligo-dT-primer with cloned Murine Leukemia Virus (MuLV) reverse transcriptase (Perkin Elmer) according to manufacturer's instructions.
First of all cDNA was subjected to amplification for housekeeping gene using primers specific for~ globin (24) to establish the suitability of the cDNA to be amplified and to verify, by serial dilution analysis, that equal amounts were employed for each sample.
In limiting dilution analysis, cDNA was serially diluted (l :3) and then amplified by using primers for El (sense 5'-TATGGCTATTCTGAAGTGGAA-3'; antisense 5' -TTGATATACCTGTTCTAAACCA-3'), E2 (sense 5'-AGGACGAGGACAAGGAAAA-3'; antisense 5' -GGATGCAGTATCAAGATTTG-3'), E6 (sense 5' -GCAAGCAACAGTT ACTGCGA-3'; antisense 5'-GTTGTCTCTGGTTGCAAATC-3') and L1 (MYll: 5'-GCMCAGGGWCATAAYAATGG-3'; MY09: 5'-CGTCCMARRGGAWACTGATC-3') genes. The amplification conditions for Eland L 1 genes were already described (25, 26) . The size of the resulting amplicons was 583 and 450 bp, respectively. For the detection of E2 and E6 mRNA the amplification was carried out by 35 cycles (94°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C for 1 min) followed by a 3.30 min period at n°c. The size of the resulting amplicons was 1139 and 420 bp, respectively (27) .
After amplification, 10 ml aliquots were analysed by electrophoresis on 2% agarose gel to detect amplified products, visualised by ethidium bromide staining. Fluorescent bands were photographed under ultraviolet light. By PCR without retro-transcription, all RNA samples analysed resulted free ofcontaminating cellular DNA (data not shown). of HPV 16 were employed. A semiquantitative peR was also performed in order to evaluate the amount of HPV DNA in HSV-2-infected and mock-infected cell cultures.
Viral DNA amplification
RESULTS
The mRNA transcription of HPV 16 early (E I, E2 and E6) and late (L I) genes in CaSki cells after HSV -2 infection was analysed. The cells were collected 20 h post HSV -2 infection when the virus was replicating but the cytopathic effect was not yet detectable. However, at this the percentage of cells showing viral antigen synthesis was higher than 90%, as demontrated by immunofluorescence assay (Fig. I) . When the infected cultures were observed for longer time, only few CaSki cells underwent morphological changes 30 h post infection, 20% of cells appeared detached after 48 h, and the cytopathic effect was complete after 72 h (data not shown). mRNA was extracted from 20 h-infected and mock-infected cells, and reverse transcription was performed. In limiting dilution analysis, cDNA was serially diluted and amplified for E I, E2, E6 and L I genes, in parallel with amplification of [3-globin gene in order to verify the equal amount of retro-transcribed DNA utilized for each sample.
Results shown in Fig.2 indicate that the transcription level of E I, E2 and E6 genes was 3fold enhanced in HSV-2 infected CaSki cells. No difference was found in both mock-and HSV-2 infected cell cultures for the major structural protein of HPV 16 (Ll).
Successively, total DNA extracted from HSV-2 infected and uninfected Caski cells was employed in PCR assays for the detection of HPV 16 E6 and [3-g1obin genes. As shown in Fig.3 the amount of HPV 16 DNA was similar in mock-or HSV-2 infected cells.
DISCUSSION
HSV-2 infection was first investigated as a putative casual agent for cervical cancer (28) , and after HPV DNA was found in cervical cancer tissues, it was hypothesised that HSV -2 infection might induce mutations and carcinogenesis of HPV -infected cervical cells (29) . Different case control studies have examined the role of HSV-2 infection in the etiology of invasive cervical cancer by using PCR-based assays to detect HPV DNA. Conflicting results were obtained but the majority of Authors showed a statistically significant association between invasive cervical cancer, type specific HSV -2 antibodies and presence of HPV DNA (30) (31) (32) (33) (34) (35) . Only in the last years in vitro studies have analysed the putative synergism between the two virus infections suggesting that a sub-fragment of HSV -2 genome may induce the malignant transformation of HPV -immortalised cervical keratinocytes (20) . In HeLa cells the modulation of HPV 18 early genes expression after HSV-2 infection has also been demonstrated (21) (22) .
Results obtained in our study add new information on the capability of HSV -2 to cooperate with HPV in transforming human cervical cells. This research represents the first report on the in vitro effect of HSV-2 infection in Caski cells, a human cervical carcinoma cell line, containing HPV -DNA type 16 integrated in cellular DNA (7) .
In HSV -2 infected CaSki cells the transcription level of HPV 16 early genes examined (E 1, E2 and E6) resulted homogenously increased whereas in HSV-2 infected HeLa cells HPV 18 early genes were found differently modulated, being E1 gene the most significantly expressed one (22) . On the other hand PCR assays provided evidence that, following HSV-2 infection, HPV 16 DNA did not increase, excl uding the possi bili ty that the enhanced HPV early gene expression could be due to a higher number of copies per cell. Furthermore, similarly to that previously observed in HSV-2infected HeLa cells, we noticed a complete lack of HPV L I transcripts in CaSki cells, allowing to confirm that herpetic infection is unable to induce the synthesis of viral late proteins leading to the yield of infecting viral particles.
Taken together results from this in vitro study and from our previous report (22) , it can be assumed that in two different carcinoma cell lines bearing HPV integrated genomic DNA, the infection with HSV -2 causes an over-expression of both HPV regulatory and oncogenic genes. These data strongly support the numerous epidemiological studies showing a significant association between invasi ve cervical cancer and infection by HSV-2 and HPV (30) (31) (32) (33) (34) (35) (36) and provide further evidences on the role of HS V-2 as cofactor of HPV infection in malignant transformation.
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